The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
The post Why Telehealth Advocates Are Calling on the Trump Administration to Withdraw New Telemedicine Rules appeared first on MedCity News.
